Nutrition drink may ease throat pain during lung cancer radiation

NCT ID NCT06840704

Recruiting now Symptom relief Sponsor: Hunan Cancer Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This phase 3 trial tests whether a daily nutritional drink (Oral Impact®) can reduce severe throat and esophagus inflammation caused by chest radiation in lung cancer patients. About 121 adults with lung cancer who need radiation will drink two bottles a day during and for three weeks after treatment. The study compares how many patients develop serious swallowing pain versus those not receiving the drink.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Oral immunonutrition (Oral Impact®)
What this could lead to: If it works, this could offer a simple, non-drug way to prevent painful swallowing during lung cancer radiation, improving quality of life.
What could go wrong: This is a mid-stage trial with 121 participants, so results may not apply to everyone. The drink may not reduce esophagitis significantly, and some people might not tolerate it.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

esophagitis non-small cell lung carcinoma small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-SMALL CELL LUNG CANCER SMALL CELL LUNG CANCER

Contacts and locations

Locations

Hunan Cancer Hospital
RECRUITING

Changsha, Hunan, 410013, China
The First People's Hospital of Chenzhou
RECRUITING

Chenzhou, Hunan, China
The Fisrt Affilated Hospital of University of South China
RECRUITING

Hengyang, Hunan, 421001, China
Third Xiangya Hospital, Central South University
RECRUITING

Changsha, Hunan, 410013, China
Xiangya Hospital of Central South University,
RECRUITING

Changsha, Hunan, China
Yueyang Central Hospital
RECRUITING

Yueyang, Hunan, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.